Loading…

THYROID PHANTOM MEASUREMENTS IN JOINT EURADOS-LLNL INTERCOMPARISON EXERCISE

The European Radiation Dosimetry Group (EURADOS), in collaboration with Lawrence Livermore National Laboratory's (LLNL's) Thyroid Intercomparison Program (TRIP), conducted an intercomparison exercise consistent with the goals of EURADOS. In total, 35 in vivo radiobioassay facilities from 1...

Full description

Saved in:
Bibliographic Details
Published in:Radiation protection dosimetry 2018-01, Vol.178 (2), p.152-159
Main Authors: Hickman, David P, Collins, Lori, Franck, Didier, Harding, Ruth N, Jeffers, Karen L, López Ponte, Maria A, Tai, Lydia I
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The European Radiation Dosimetry Group (EURADOS), in collaboration with Lawrence Livermore National Laboratory's (LLNL's) Thyroid Intercomparison Program (TRIP), conducted an intercomparison exercise consistent with the goals of EURADOS. In total, 35 in vivo radiobioassay facilities from 18 countries participated to evaluate the differences between the neck and thyroid phantoms specified in two standards issued by the American National Standards Institute. Radioiodine (125I and 131I) measurement results were compared to the traceable standard activity levels added to each phantom. Measurement data showed no statistically significant differences between normalized activity measurements of the thyroid phantom types (20 and 30 ml). Differences were noted between the laboratories that routinely participate in the radioiodine thyroid intercomparison program (TRIP participants) and laboratories that have not previously participated in TRIP. Evaluation of the reasons for these differences will require additional EURADOS-LLNL collaborations. Finally, the measurement data from this intercomparison was used with a designed intake scenario for intercomparison of dose evaluations. Results from the dose intercomparison will be presented in a subsequent article.
ISSN:0144-8420
1742-3406
DOI:10.1093/rpd/ncx094